Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retrospective Study in China
Author(s) -
Chang Liu,
Ting Li,
Zhonghua Tao,
Jun Cao,
Leiping Wang,
Jian Zhang,
Biyun Wang,
Xichun Hu
Publication year - 2020
Publication title -
medical science monitor
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.636
H-Index - 85
eISSN - 1643-3750
pISSN - 1234-1010
DOI - 10.12659/msm.927187
Subject(s) - palbociclib , medicine , metastatic breast cancer , oncology , breast cancer , cancer , progression free survival , chemotherapy , gynecology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom